Two Distinct Functional Patterns of Hepatitis C Virus (HCV)-Specific T Cell Responses in Seronegative, Aviremic Patients

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Choi, Yoon Seok ^a,b   Lee, Jung Eun ^c   Nam, Seung Joo ^a   Park, Jung Tak ^c   Kim, Hyon Suk ^c   Choi, Kyu Hun ^c   Kim, Beom Seok ^c   Shin, Eui Cheol ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN; VIRUS RNA; CYTOKINE;

ADULT; ARTICLE; CELLULAR IMMUNITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN CELL; INFECTION RISK; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; AGED; BLOOD; HEPACIVIRUS; IMMUNOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SERODIAGNOSIS; T LYMPHOCYTE; VIROLOGY;

HEPATITIS C VIRUS;

AGED; CYTOKINES; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV SERONEGATIVITY; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; T-LYMPHOCYTES;

EID: 84876987415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062319     Document Type: Article

References (45)

1. Alter HJ, Seeff LB, (2000) Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 20: 17-35.
2. Seeff LB, (2002) Natural history of chronic hepatitis C. Hepatology 36: S35-46.
3. Shepard CW, Finelli L, Alter MJ, (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
4. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512.
5. Rosen HR, Miner C, Sasaki AW, Lewinsohn DM, Conrad AJ, et al. (2002) Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology 35: 190-198.
6. Day CL, Lauer GM, Robbins GK, McGovern B, Wurcel AG, et al. (2002) Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76: 12584-12595.
7. Mizukoshi E, Eisenbach C, Edlin BR, Newton KP, Raghuraman S, et al. (2008) Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis 198: 203-212.
8. Al-Sherbiny M, Osman A, Mohamed N, Shata MT, Abdel-Aziz F, et al. (2005) Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion. Am J Trop Med Hyg 73: 44-49.
9. Bronowicki JP, Vetter D, Uhl G, Hudziak H, Uhrlacher A, et al. (1997) Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. J Infect Dis 176: 518-522.
10. Scognamiglio P, Accapezzato D, Casciaro MA, Cacciani A, Artini M, et al. (1999) Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors. J Immunol 162: 6681-6689.
11. Hashem M, El-Karaksy H, Shata MT, Sobhy M, Helmy H, et al. (2011) Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children. J Infect Dis 203: 854-861.
12. Koziel MJ, Wong DK, Dudley D, Houghton M, Walker BD, (1997) Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons. J Infect Dis 176: 859-866.
13. Perrella A, Grattacaso S, d'Antonio A, Atripaldi L, Sbreglia C, et al. (2009) Evidence of hepatitis C virus-specific interferon gamma-positive T cells in health care workers in an infectious disease department. Am J Infect Control 37: 426-429.
14. Welker MW, Zeuzem S, (2009) Occult hepatitis C: how convincing are the current data? Hepatology 49: 665-675.
15. Quiroga JA, Llorente S, Castillo I, Rodriguez-Inigo E, Pardo M, et al. (2006) Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol 80: 10972-10979.
16. Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B, (2001) Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol 75: 11392-11400.
17. Urbani S, Amadei B, Fisicaro P, Pilli M, Missale G, et al. (2005) Heterologous T cell immunity in severe hepatitis C virus infection. J Exp Med 201: 675-680.
18. Rehermann B, Shin EC, (2005) Private aspects of heterologous immunity. J Exp Med 201: 667-670.
19. Post JJ, Pan Y, Freeman AJ, Harvey CE, White PA, et al. (2004) Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J Infect Dis 189: 1846-1855.
20. Shata MT, Tricoche N, Perkus M, Tom D, Brotman B, et al. (2003) Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology 314: 601-616.
21. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, et al. (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 6: 578-582.
22. Bassett SE, Guerra B, Brasky K, Miskovsky E, Houghton M, et al. (2001) Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33: 1479-1487.
23. Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, et al. (2003) Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 77: 4781-4793.
24. Lanford RE, Guerra B, Chavez D, Bigger C, Brasky KM, et al. (2004) Cross-genotype immunity to hepatitis C virus. J Virol 78: 1575-1581.
25. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, et al. (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662.
26. Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, et al. (2003) Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 197: 1645-1655.
27. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
28. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al. (2006) HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
29. Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, et al. (2007) Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 204: 1405-1416.
30. Shin EC, Park SH, Demino M, Nascimbeni M, Mihalik K, et al. (2011) Delayed induction, not impaired recruitment, of specific CD8 T cells causes the late onset of acute hepatitis C. Gastroenterology 141: 686-695, 695 e681.
31. Shin EC, Protzer U, Untergasser A, Feinstone SM, Rice CM, et al. (2005) Liver-directed gamma interferon gene delivery in chronic hepatitis C. J Virol 79: 13412-13420.
32. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, et al. (2004) Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78: 5867-5874.
33. Castillo I, Rodriguez-Inigo E, Bartolome J, de Lucas S, Ortiz-Movilla N, et al. (2005) Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 54: 682-685.
34. Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V, (2010) Diagnosis of occult hepatitis C without the need for a liver biopsy. J Med Virol 82: 1554-1559.
35. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Inigo E, et al. (2004) Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189: 7-14.
36. Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, et al. (2008) Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol 19: 2288-2292.
37. De Maria A, Cirillo C, Moretta L, (1994) Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 170: 1296-1299.
38. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, et al. (1997) HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 3: 1250-1257.
39. Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, et al. (1998) Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 102: 1758-1765.
40. Quaratino S, Thorpe CJ, Travers PJ, Londei M, (1995) Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc Natl Acad Sci U S A 92: 10398-10402.
41. Park SH, Shin EC, Capone S, Caggiari L, De Re V, et al. (2012) Successful Vaccination Induces Multifunctional Memory T-Cell Precursors Associated with Early Control of Hepatitis C Virus. Gastroenterology.
42. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, et al. (2011) Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 17: 372-376.
43. Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, et al. (2005) T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet 365: 327-329.
44. Bes M, Esteban JI, Casamitjana N, Piron M, Quer J, et al. (2009) Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure. Transfusion 49: 1296-1305.
45. Hitziger T, Schmidt M, Schottstedt V, Hennig H, Schumann A, et al. (2009) Cellular immune response to hepatitis C virus (HCV) in nonviremic blood donors with indeterminate anti-HCV reactivity. Transfusion 49: 1306-1313.